The Involvement of Mitochondrial Amidoxime Reducing Components 1 and 2 and Mitochondrial Cytochrome b5 in N-Reductive Metabolism in Human Cells
Open Access
- 1 July 2013
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (28) , 20228-20237
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Variants Identified in a GWAS Meta-Analysis for Blood Lipids Are Associated with the Lipid Response to FenofibratePLOS ONE, 2012
- Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivityPharmacogenetics and Genomics, 2012
- Amidoxime Reductase System Containing Cytochrome b5 Type B (CYB5B) and MOSC2 Is of Importance for Lipid Synthesis in Adipocyte MitochondriaJournal of Biological Chemistry, 2012
- Molybdenum enzymes in higher organismsCoordination Chemistry Reviews, 2011
- Individual Variability in the Detoxification of Carcinogenic Arylhydroxylamines in Human BreastToxicological Sciences, 2011
- Biochemical and Spectroscopic Characterization of the Human Mitochondrial Amidoxime Reducing Components hmARC-1 and hmARC-2 Suggests the Existence of a New Molybdenum Enzyme Family in EukaryotesJournal of Biological Chemistry, 2010
- Biological, clinical and population relevance of 95 loci for blood lipidsNature, 2010
- Cytochrome b5 and NADH cytochrome b5 reductase: genotype–phenotype correlations for hydroxylamine reductionPharmacogenetics and Genomics, 2010
- BioGPS: an extensible and customizable portal for querying and organizing gene annotation resourcesGenome Biology, 2009
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970